STRO
Sutro Biopharma Inc
$3.89
Earnings Summary
Revenue | $113.72Mn |
Net Profits | $31.07Mn |
Net Profit Margins | 27.32% |
Highlights
Sutro Biopharma Inc’s revenue jumped 1217.44% since last year same period to $113.72Mn in the Q4 2023. On a quarterly growth basis, Sutro Biopharma Inc has generated 571.95% jump in its revenue since last 3-months.
Sutro Biopharma Inc’s net profit jumped 183.75% since last year same period to $31.07Mn in the Q4 2023. On a quarterly growth basis, Sutro Biopharma Inc has generated 163.03% jump in its net profits since last 3-months.
Sutro Biopharma Inc’s net profit margin jumped 106.36% since last year same period to 27.32% in the Q4 2023. On a quarterly growth basis, Sutro Biopharma Inc has generated 109.38% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Sutro Biopharma Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.92 |
EPS Estimate Current Year | -0.92 |
Highlights
Sutro Biopharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.92 - a -12.2% fall from last quarter’s estimates.
Sutro Biopharma Inc’s earning per share (EPS) estimates for the current year stand at -0.92.
Key Ratios
Key ratios of the Sutro Biopharma Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 0.52 |
Highlights
Sutro Biopharma Inc’s earning per share (EPS) jumped 176.47% since last year same period to 0.52 in the Q4 2023. This indicates that the Sutro Biopharma Inc has generated 176.47% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-25 | -0.82 | 0.52 | 163.41% |
2023-05-15 | -0.81 | -0.85 | -4.94% |
2023-08-10 | -0.73 | -0.64 | 12.33% |
2023-11-13 | -0.74 | -0.81 | -9.46% |
₹0 US Stocks a/c Opening Fee